- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01902654
Osteoarthritis Cardiovascular Risk Factors
February 9, 2014 updated by: Joan Calvet Fontova, Hospital Parc Taulí, Sabadell
Prevalence of Cardiovascular Risk Factors Between Patients With Knee or Hand Osteoarthritis
We analyze retrospectively the relationship between traditional cardiovascular risk factors as hypertension, obesity, dislipidemia and diabetes and hand or knee osteoarthritis and we compare the results with a control groups of patients with soft tissue disease with no other rheumatologic condition.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
490
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Recruiting
- Hospital Parc Tauli Sabadell
-
Contact:
- Orellana Cristobal, Dr
- Phone Number: 24065 0034937231010
- Email: corellana@tauli.cat
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients referred to the rheumatology outpatient for symptomatic hand or knee osteoarthritis or soft tissue disease.
Patients were referred by their primary care physician, and all patients were visited in primary care assitance.
Description
Inclusion Criteria:
- Patients referred for symptomatic hand or knee osteoarthritis
- All patients referred in the same period for soft tissue disease
- > 50 years old
Exclusion Criteria:
- Any other rheumatologic condition
- secondary osteoarthritis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Knee osteoarthritis
Patients over 50 years who presented to an outpatient rheumatology for 1 year and who had knee osteoarthritis.
|
We look over patient medical record and we collect the diagnoses associated with cardiovascular risk factor as hypertension, obesity, dislipidemia and diabetes.
In all patient we collect the history of cardiovascular disease.
We have defined two groups according to grouping of none, 1 or 2 cardiovascular risk factors or 3 or more.
|
Hand osteoarthritis
Patients over 50 years who presented to an outpatient rheumatology for 1 year and who had hand osteoarthritis.
|
We look over patient medical record and we collect the diagnoses associated with cardiovascular risk factor as hypertension, obesity, dislipidemia and diabetes.
In all patient we collect the history of cardiovascular disease.
We have defined two groups according to grouping of none, 1 or 2 cardiovascular risk factors or 3 or more.
|
Soft tissue disease
All patients over 50 years who presented during the same period of time of other cohorts, to an outpatient rheumatology and who had soft tissue disease with no other rheumatic condition.
|
We look over patient medical record and we collect the diagnoses associated with cardiovascular risk factor as hypertension, obesity, dislipidemia and diabetes.
In all patient we collect the history of cardiovascular disease.
We have defined two groups according to grouping of none, 1 or 2 cardiovascular risk factors or 3 or more.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of cardiovascular risk factors in hand or knee osteoarthritis patients
Time Frame: one month
|
We analyze the prevalence of cardiovascular risk factors in a cohort of knne osteoarthritis and in a cohort of hand osteoarthritis.
Then we evaluate the prevalence of cardiovascular risk factors in a cohort of soft tissue disease patients.
Finally we compare osteoarthritis patients with soft tissue disease patients.
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of cardiovascular disease in hand or knee osteoarthritis.
Time Frame: one month
|
We evaluate the prevalence of cardiovascular disease in the three cohorts, hand osteoarthritis, knee osteoarthritis and soft tissue disease; and we compare them.
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: jordi Gratacos, MD Ph, Hospital Parc Tauli
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (ANTICIPATED)
February 1, 2014
Study Registration Dates
First Submitted
July 9, 2013
First Submitted That Met QC Criteria
July 16, 2013
First Posted (ESTIMATE)
July 18, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
February 11, 2014
Last Update Submitted That Met QC Criteria
February 9, 2014
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Joan02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
Clinical Trials on Cardiovascular risk factors diagnoses collection.
-
Institut National de la Santé Et de la Recherche...Completed
-
Jordan Collaborating Cardiology GroupCompletedCardiovascular Diseases | Risk FactorsJordan
-
University Hospital, EssenCompletedCardiovascular Diseases | Cardiovascular Risk Factor | SARSGermany
-
Escola Superior de Tecnologia da Saúde do PortoCompletedAcute Myocardial InfarctionPortugal
-
Pr. Nicolas GIRERDCompletedCardiovascular DiseasesFrance
-
Institut Investigacio Sanitaria Pere VirgiliWithdrawnStroke | Risk Factor, CardiovascularSpain
-
Caroline Medical GroupHealth CanadaUnknownHyperglycemia | Smoking | Hypertension | Cardiovascular Disease | HyperlipidemiaCanada
-
Universidad de LeónConsejo General de Colegios Oficiales de Enfermería EspañaActive, not recruitingAlzheimer DiseaseSpain
-
ASST Fatebenefratelli SaccoTommaso Fossali; Beatrice Borghi; Emanuele Catena; Andrea PerottiCompletedPostoperative Myocardial IschemiaItaly
-
UCB BIOSCIENCES, Inc.CompletedEpilepsyCzechia, Germany, Poland, Austria, Belgium, Brazil, Canada, Estonia, Finland, France, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Puerto Rico, Russian Federation, Spain, Sweden, T... and more